| First Author | Reina-Campos M | Year | 2019 |
| Journal | Cancer Cell | Volume | 36 |
| Issue | 3 | Pages | 218-235 |
| PubMed ID | 31474570 | Mgi Jnum | J:279352 |
| Mgi Id | MGI:6360769 | Doi | 10.1016/j.ccell.2019.07.010 |
| Citation | Reina-Campos M, et al. (2019) The Dual Roles of the Atypical Protein Kinase Cs in Cancer. Cancer Cell 36(3):218-235 |
| abstractText | Atypical protein kinase C (aPKC) isozymes, PKClambda/iota and PKCzeta, are now considered fundamental regulators of tumorigenesis. However, the specific separation of functions that determine their different roles in cancer is still being unraveled. Both aPKCs have pleiotropic context-dependent functions that can translate into tumor-promoter or -suppressive functions. Here, we review early and more recent literature to discuss how the different tumor types, and their microenvironments, might account for the selective signaling of each aPKC isotype. This is of clinical relevance because a better understanding of the roles of these kinases is essential for the design of new anti-cancer treatments. |
